Lini Pandite

1.2k citations
9 papers · 565 indexed · 1 hit paper · h-index 8
Topics
HER2/EGFR in Cancer Research (4 papers)Chronic Lymphocytic Leukemia Research (4 papers)Lung Cancer Treatments and Mutations (4 papers)

In The Last Decade

Lini Pandite

9 papers receiving 552 citations

Hit Papers

Dabrafenib in patients with BRAFV600E-positive advanced n...20162026201920222016100200300

Peers

Lini Pandite
Comparison fields: 5 of 48
  • Oncology 385
  • Pulmonary and Respiratory Medicine 318
  • Molecular Biology 243
  • Cancer Research 118
  • Pathology and Forensic Medicine 76
Replace Samuel Tracy with:
Samuel Tracy United States
Brooke Esteves United States
Max Hallin United States
S. Johnston United Kingdom
Feng-yi Feng China
Patricia Tresca France
G. Jeannin France
Douglas Robinson United States
L. Véronèse Switzerland
Kerstin Trunzer Switzerland
Lini Pandite relative to Samuel Tracy United States Samuel Tracy's profile →
Citations per field
00.5×3.4×
Samuel Tracy · 1×
Citations per year

Countries citing papers authored by Lini Pandite

Since Specialization
Citations

This map shows the geographic impact of Lini Pandite's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lini Pandite with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lini Pandite more than expected).

Fields of papers citing papers by Lini Pandite

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lini Pandite. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lini Pandite. The network helps show where Lini Pandite may publish in the future.

Co-authorship network of co-authors of Lini Pandite

This figure shows the co-authorship network connecting the top 25 collaborators of Lini Pandite. A scholar is included among the top collaborators of Lini Pandite based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lini Pandite. Lini Pandite is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 9
2
Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trialbreakdown →
334
3 33
4 89
5 48
6 21
7 20
8 7
9 4

About Lini Pandite

Lini Pandite is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 565 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Oncology (385 citations), Pulmonary and Respiratory Medicine (318 citations) and Cancer Research (118 citations). Lini Pandite has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Pierre‐Jean Souquet, Bijoyesh Mookerjee, Fabrice Barlési, Bruce E. Johnson, C. Martin Curtis, Julien Mazières, Bo Ma, Tae Min Kim, Byoung Chul Cho and Egbert F. Smit. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026